Onco-Innovations Announces $2 Million Private Placement

Onco-Innovations Limited, headquartered in Vancouver, has announced plans for a non-brokered private placement aiming to raise up to $2 million. The offering includes up to 1,428,572 units priced at $1.40 each. Each unit comprises one common share and a half-share warrant, with warrants exercisable at $2.00 over 36 months.

The company intends to allocate 1% of the shares issued to a third party as an administrative fee. Additional finder’s fees may be awarded to parties introducing subscribers to the placement. Subject to regulatory approval, the offering’s closure will occur after a securities hold period of four months. Funds will fuel corporate and R&D activities.

Onco-Innovations also appointed Christopher Gulka to its board. With 30 years in capital markets, Gulka replaces Graydon Bensler, who is acknowledged for his service.